Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target ; volume:24 ; number:1 ; day:19 ; month:8 ; year:2024 ; pages:1-20 ; date:12.2024
BMC cancer ; 24, Heft 1 (19.8.2024), 1-20, 12.2024
- Creator
-
Chen, Dongshan
Cao, Haoyuan
Zheng, Xiang
Wang, Haojun
Han, Zengchi
Wang, Wei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12790-w
- URN
-
urn:nbn:de:101:1-2411052102189.969468370167
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Dongshan
- Cao, Haoyuan
- Zheng, Xiang
- Wang, Haojun
- Han, Zengchi
- Wang, Wei
- SpringerLink (Online service)
Other Objects (12)
Cellular senescence affects energy metabolism, immune infiltration and immunotherapeutic response in hepatocellular carcinoma
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
A gut microbial signature for combination immune checkpoint blockade across cancer types
Neurosarcoidosis following Immune Checkpoint Inhibition
Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors
Immune responses and immunotherapeutic approaches in the treatment against cancer
Cellular senescence affects energy metabolism, immune infiltration and immunotherapeutic response in hepatocellular carcinoma
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
A gut microbial signature for combination immune checkpoint blockade across cancer types
Neurosarcoidosis following Immune Checkpoint Inhibition
Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors
Immune responses and immunotherapeutic approaches in the treatment against cancer
Cellular senescence affects energy metabolism, immune infiltration and immunotherapeutic response in hepatocellular carcinoma
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
A gut microbial signature for combination immune checkpoint blockade across cancer types
Neurosarcoidosis following Immune Checkpoint Inhibition
Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors